ABSTRACT
All the plants are having medicinal values and thus are used traditionally in many diseasesfrom ancient times. One of such useful plant is Aerva lanata commonly known as “Bhui” which is awoody, prostate or succulent, perennial herb from the Amaranthaceae family, found in open forest onmountains, slopes, disturbed ground and deserted areas(1). The plant has been screened for diuretic,antidiabetic, anti-inflammatory and hepatoprotective activity (2) (3). According to the literature referredthe pharmacognostical studies of this plant have not been reported yet, therefore the presentinvestigation is planned to study the pharmacognostical and phytochemical aspects of Aerva lanata. Inthe present research article the pharmacognostical study i.e. morphological, microscopical, chemical &chromatographic analysis of plant Aerva lanata was carried out. This study provides the standardizationparameters important for the characterization & identification of the plant. The information will beuseful for the traditional medicine practitioners & establishing literature regarding the plant.Microscopic studies shows upper epidermis is straight walled, single layered containing trichomesbelow the epidermis collenchyma cellular layers are present which can be characterized by thickcellulosic deposition. Cells contain calcium oxalate crystals (in small amount) and starch. Vascularbundles present in spongy tissues. Physiochemical analysis shows Total ash, Acid insoluble ash, Watersoluble ash, Sulphated ash values as 10.01%, 2.01%, 4.92% and 4.82% respectively. Other parameterslike Alcohol soluble extractive value, Water soluble extractive value, Loss on drying and swelling indexare found to be 20%, 24%, 8% and 6.42%. Fluorescence study and preliminary phytochemical tests arealso performed. Thin layer chromatographic studies showing presence of carbohydrates, steroids,flavonoids and tannins at Rf values of 0.88, 0.86, 0.92 and 0.86 respectively.
ABSTRACT
In the present work, Independent method was developed for estimation of Chlorhexidine Gluconate, Metronidazole benzoate,Lignocaine Hydrochloride, and Salicylic Acid in bulk and dosage form by UV-Visible Spectrophotometry. In this method the determination ofmaximum absorbance (λmax) of the drugs were found to be 259 nm, 285.8 nm, 263 nm and 304 nm. The validation parameters were studiedaccording to ICH guidelines. On the basis of % agreement criteria, therefore Average % agreement found to be 100.05 at 259 nm, 99.32 at285.8 nm, 100.001 at 304 nm and 99.70 at 263 nm. Specificity study shows the good agreement with results, indicating that excipients did notinterfere with the analyte. Repeatability study showed a % R.S.D of 0.2486 at 259 nm, 0.2605 at 285.8 nm, 0.403174 at 304 nm and 0.880817at 263 nm for Chlorhexidine Gluconate, Metronidazole benzoate, Lignocaine Hydrochloride, and Salicylic Acid. Thus it is concluded that theanalytical technique has a good repeatability precision as R.S.D are less than 5.3% (Specified) and less than 2% (desired). So it can be said thatthe proposed method is precise. Intraday study were showed a % R.S.D of 1.246918, 0.984763, 0.775939 and 1.022045 respectively forChlorhexidine Gluconate, Metronidazole benzoate, Lignocaine Hydrochloride, and Salicylic Acid. So it can be said that the proposed method isprecise. Interday study were showed a % R.S.D of 1.358486, 0.829325, 1.273356 and 0.968196 respectively for Chlorhexidine Gluconate,Metronidazole benzoate, Lignocaine Hydrochloride, and Salicylic Acid. So it can be said that the proposed method is precise. Limit of detectionwere found to be 0.097, 0.117, 0.010 and 0.074 g/ml at 259, 285.8, 304and 263 nm. Limit of quantification were found to be 0.29, 0.35, 0.030and 0.418 g/ml at 259, 285.5 304, and 263nm. The accuracy of the methods was proved by performing recovery studies in availableformulations. Since the % recovery 98.07 to 101.28 at 259 nm, 98.29 to 101.02 at 285.8 nm, 99.99 to 101.25 at 304nm and 99.10 to 101.78 at263nm are within the desirable confidence interval of 98-102%. So it can be said that the proposed method is accurate. The percent meanrecovery is 98.46, 101.42 (1:3), 98.20 and 99.78% of labeled amount, which is within specified limits of 98-102%. It can be said that proposedmethod can satisfactory be applied for analysis of Chlorhexidine Gluconate, Metronidazole benzoate, Lignocaine Hydrochloride, and SalicylicAcid in dosage form. The developed method is precise, accurate and do not suffer from any interference due to common excipients. It isevident from this study that the developed method is simple, sensitive, specific, precise and accurate and economic. Hence it can be employedfor routine analysis in quality control laboratories.